SCHEMBL8439461

SCHEMBL8439461

CCN(c1ccncc1)c1csc2cccnc12

nearest known ligand 0.35

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.34
L3MBTL1 Q9Y468 3/20 0.31
NPC1 O15118 2/20 0.31
MAPK14 Q16539 1/20 0.31
HSP90AA1 P07900 1/20 0.31
MAPT P10636 1/20 0.31
MAPK1 P28482 1/20 0.31
SLC6A2 P23975 1/20 0.30
KDM4E B2RXH2 1/20 0.30
RAB9A P51151 1/20 0.30
CHRM5 P08912 1/20 0.30
CHKA P35790 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8439457 0.89 SLC6A2 (0.35) ALDH1A1SLC6A2
SCHEMBL8439939 0.87 SLC6A2 (0.35) ALDH1A1L3MBTL1HSP90AA1MAPTMAPK1
SCHEMBL8440150 0.81 CHRM5 (0.36) L3MBTL1NPC1MAPK14HSP90AA1MAPT
SCHEMBL8056316 0.80 SLC6A2 (0.38) ALDH1A1MAPK14MAPTSLC6A2
Hydrochloric Acid SCHEMBL8039091 0.79 ALDH1A1 (0.40) ALDH1A1MAPK14MAPTSLC6A2
SCHEMBL9004605 0.78 IRAK4 (0.33) ALDH1A1L3MBTL1NPC1HSP90AA1MAPK1
SCHEMBL8306498 0.78 ALDH1A1 (0.44) ALDH1A1L3MBTL1NPC1HSP90AA1MAPT
SCHEMBL8442576 0.76 NSD2 (0.36) ALDH1A1L3MBTL1NPC1KDM4ERAB9A
SCHEMBL8435887 0.74 LATS1 (0.38) CHRM5CHKA
SCHEMBL8440389 0.74 CYP2A6 (0.40) SLC6A2CHRM5CHKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5856335-A GLYCINE PARTIAL AGONISTS. HOECHST MARION ROUSSEL, INC. (US) 1999-01-05 US disclosed
US-5519032-A ANTIDEPRESSANTS, ANXIOLYTICS, ANTIEMETICS, ANTIPSYCHOTIC HOECHST MARION ROUSSEL INC. (US) 1996-05-21 US disclosed
EP-0581106-A1 Substituted aminothienopyridines, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1994-02-02 EP disclosed
US-5252581-A Modulators of neurotransmitters HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1993-10-12 US disclosed